Shawn O'Brien

Chief Executive Officer, Managing Director / Mayne Pharma Group

Mr O'Brien has more than 35 years of global pharmaceutical industry experience building enterprises. He was a founding partner of Key BioPharma Partners providing advice to life science companies and capital providers. He was previously the Chairman and CEO of Genomind Inc., a personalised mental health platform company, and CEO of publicly listed Cipher Pharmaceuticals Inc., a specialty pharmaceutical company with a portfolio of commercial stage dermatology products. He has also been President and CEO of three private biotechs including AltheRx Pharmaceuticals, Profectus BioSciences and Solstice Neurosciences. Mr O'Brien held multiple senior leadership roles at AstraZeneca, one of the global pharmaceutical companies. At AstraZeneca he was responsible for key brands such as FASLODEX, SYMBICORT, PULMICORT and SEROQUEL which all became billion-dollar brands.

Lists and Charts

Roles

2022

Chief Executive Officer, Managing Director

Mayne Pharma Group

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
893^rd	New Hope Corporation	-2%	28.65%
894^th	Viva Leisure	-2.12%	-13.3%
895^th	Mayne Pharma Group	-2.14%	-11.16%
896^th	NSX	-2.69%	-32.23%
897^th	Flight Centre Travel Group	-2.75%	-13.93%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Chief Executive Officer, Managing Director, Mayne Pharma Group

01 Aug 2024

Related Information

Access to our data for Shawn O'Brien is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Shawn O'Brien is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.